We are live on ! Find out more
MRT

MedEquities Realty Trust, Inc.
MRT

Delisted

MRT was delisted on the 16th of May, 2019.

102 hedge funds and large institutions have $319M invested in MedEquities Realty Trust, Inc. in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

5% more funds holding

Funds holding: 97102 (+5)

2% more capital invested

Capital invested by funds: $314M → $319M (+$5.61M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
102
Holders Change
+5
Holders Change %
+5.15%
% of All Funds
2.34%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
10
Increased
40
Reduced
34
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$32.5M +$9.55M +924,892 +46%
Prudential Financial
2
Prudential Financial
New Jersey
$27.6M +$1.91M +185,118 +8%
Goldman Sachs
3
Goldman Sachs
New York
$27M -$204K -19,759 -0.8%
AIM
4
Assured Investment Management
New York
$24.2M -$4M -388,008 -15%
American Century Companies
5
American Century Companies
Missouri
$23.9M +$688K +66,695 +3%
BlackRock
6
BlackRock
New York
$16.5M +$804K +77,884 +5%
N
7
Nuveen
North Carolina
$16.3M +$776K +75,196 +5%
Invesco
8
Invesco
Georgia
$16.2M +$272K +26,356 +2%
ACB
9
Aristotle Capital Boston
Massachusetts
$10.1M -$469K -45,402 -5%
Renaissance Technologies
10
Renaissance Technologies
New York
$9.26M +$2.3M +222,500 +36%
EBIM
11
Eagle Boston Investment Management
Massachusetts
$8.63M +$349K +33,834 +5%
Charles Schwab
12
Charles Schwab
California
$8.43M +$52.7K +5,106 +0.7%
State Street
13
State Street
Massachusetts
$7.5M +$234K +22,680 +3%
NIMC
14
NWQ Investment Management Company
California
$6.82M -$48.7K -4,716 -0.8%
SCM
15
Stadium Capital Management
Connecticut
$6.17M
SAM
16
Silvercrest Asset Management
New York
$5.03M +$50.3K +4,875 +1%
Boston Partners
17
Boston Partners
Massachusetts
$3.96M -$6.26M -606,101 -63%
TCIM
18
TIAA CREF Investment Management
New York
$3.94M -$706K -68,416 -16%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$3.9M -$12K -1,166 -0.3%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$3.77M -$274K -26,518 -7%
SEI Investments
21
SEI Investments
Pennsylvania
$3.65M +$284K +27,562 +9%
PAM
22
Panagora Asset Management
Massachusetts
$3.65M -$569K -55,120 -14%
Northern Trust
23
Northern Trust
Illinois
$3.56M +$79.1K +7,661 +2%
Man Group
24
Man Group
United Kingdom
$3.33M +$1.44M +139,451 +86%
MAM
25
Martingale Asset Management
Massachusetts
$2.85M +$52.6K +5,100 +2%

MRT Hedge Fund Activity: Q2 2018 in Review

102 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in MedEquities Realty Trust, Inc. (MRT) for Q2 2018, worth a combined $319M — up 1.8% from $314M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MRT positions and 5 closed out — a net gain of 5 holders — while 40 added to existing stakes and 34 trimmed.

The largest buyer was Vanguard Group, adding an estimated $9.55M. The largest seller was Russell Investments Group, cutting an estimated $11.9M.

  • 102 institutional investors held MedEquities Realty Trust, Inc. (MRT) as of Q2 2018, up from 97 in Q1 2018.
  • Funds reported $319M of MedEquities Realty Trust, Inc. stock for Q2 2018, up 1.8% quarter-over-quarter.
  • 10 funds opened new MedEquities Realty Trust, Inc. positions in Q2 2018 and 5 closed out, a net change of +5 holders.
  • The largest MedEquities Realty Trust, Inc. buyer in Q2 2018 was Vanguard Group, an estimated $9.55M added.
  • The largest MedEquities Realty Trust, Inc. seller in Q2 2018 was Russell Investments Group, an estimated $11.9M sold.

Based on aggregated 13F filings for Q2 2018.